Amylyx Pharmaceuticals Inc. (AMLX)
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Amylyx Pharmaceuticals, Inc. – AMLX
Zimmer Biomet Holdings Inc (ZBH)
Securities Fraud Investigation Into Zimmer Biomet Holdings, Inc. (ZBH) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
ResMed Inc (RMD)
New SEC Form for ResMed Inc.
Milestone Scientific (MLSS)
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
Eli Lilly and Company (LLY)
Statement: Eli Lilly has no affiliation with Mangoceuticals, Inc.
Auxly Cannabis Group Inc. (CBWTF)
Auxly Reports Third Quarter 2025 Results
60 Degrees Pharmaceuticals Inc (SXTP)
60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
Bioxytran, Inc. (BIXT)
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research
Cue Biopharma Inc. (CUE)
Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments
Windtree Therapeutics Inc. (WINT)
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company